Los Angeles-based QT plans for the funding to accelerate its market penetration, global expansion, product development and long-term planning.
The company develops cardiac devices for patients with heart disease. Its flagship Personal Cardiac Assistant (PCA 500), a hospital-grade, resting 12-lead ECG device, has FDA clearance and CE mark. The company designed its wireless, digital, cloud-managed device for convenience with its small size. It weighs 2.3 ounces and measures less than three square inches in size. Smaller than a deck of cards, it fits in a shirt pocket or mailing envelope and utilizes phone and tablet apps.
QT Medical says its proprietary single-use, self-adhesive sensor replaces traditional electrodes and wires. Current uses include commercial flights for inflight medical …